Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OrthoPediatrics ( (KIDS) ) has shared an update.
OrthoPediatrics filed a brief disclosure indicating that information previously provided under one reporting item is being incorporated by reference into another. This technical cross-reference suggests there is no new operational or strategic development being announced, but rather an internal alignment of existing regulatory disclosures for reporting consistency.
The most recent analyst rating on (KIDS) stock is a Hold with a $15.50 price target. To see the full list of analyst forecasts on OrthoPediatrics stock, see the KIDS Stock Forecast page.
Spark’s Take on KIDS Stock
According to Spark, TipRanks’ AI Analyst, KIDS is a Neutral.
The score is driven primarily by mixed financial performance: strong revenue growth and healthy gross margins are offset by ongoing losses and still-weak cash flow. The earnings call adds support via credible improvement guidance (EBITDA expansion and FCF breakeven target), while technicals are neutral-to-mixed and valuation is constrained by a negative P/E and no dividend.
To see Spark’s full report on KIDS stock, click here.
More about OrthoPediatrics
Average Trading Volume: 158,658
Technical Sentiment Signal: Sell
Current Market Cap: $401.2M
For detailed information about KIDS stock, go to TipRanks’ Stock Analysis page.